shouldn't come as a surprise - doesn't surprise me BUT:
1) comment that any lawsuit will not "materially" impact the company - would love to know how they define "materially";
2) love the way they introduced the "potential" pipeline before hitting us with the litigation issue - gosh how silly are we to fall for the one-two hit;
3) potential development pipeline late calendar year 2017 - hmmm
4) if litigation lost then depending on how long in courts and whether competing products are able to sell whilst litigation on - could have a large impact on sales;
5) always the issue with this "one trick pony". competitors - and what would explain the rather lacklustre approach to R&D in the past few years - too much resting on ones laurels maybe??
6) surprised that the opportunity was not taken to inform us on the ins-outs of the Helix matter![]()
- Forums
- ASX - By Stock
- ACR
- Ann: Acrux generic strategy and Axiron patent litigation update-ACR.AX
ACR
acrux limited
Add to My Watchlist
5.56%
!
1.7¢

Ann: Acrux generic strategy and Axiron patent litigation update-ACR.AX, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.7¢ |
Change
-0.001(5.56%) |
Mkt cap ! $6.931M |
Open | High | Low | Value | Volume |
1.8¢ | 1.9¢ | 1.7¢ | $8.809K | 495.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 266679 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.8¢ | 252359 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 266679 | 0.017 |
1 | 218000 | 0.016 |
2 | 266732 | 0.015 |
1 | 70000 | 0.014 |
2 | 397000 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 252359 | 2 |
0.019 | 677115 | 3 |
0.020 | 670000 | 3 |
0.021 | 203466 | 1 |
0.022 | 118000 | 2 |
Last trade - 14.49pm 24/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |